Your browser doesn't support javascript.
Safety of mRNA COVID-19 vaccinations in patients with allergic diseases.
Rosada, Tomasz; Napiórkowska-Baran, Katarzyna; Cala, Lukasz; Alska, Ewa; Paulina, Kesicka; Czarnowska, Marta; Bartuzi, Zbigniew.
  • Rosada T; Department and Clinic of Allergology, Clinical Immunology and Internal Diseases, Ludwik Rydygier Collegium Medicum in Bydgoszcz, Nicolaus Copernicus University in Torun, Dr Jan Biziel University Hospital No. 2 in Bydgoszcz, Poland.
  • Napiórkowska-Baran K; Department and Clinic of Allergology, Clinical Immunology and Internal Diseases, Ludwik Rydygier Collegium Medicum in Bydgoszcz, Nicolaus Copernicus University in Torun, Dr Jan Biziel University Hospital No. 2 in Bydgoszcz, Poland.
  • Cala L; Department and Clinic of Allergology, Clinical Immunology and Internal Diseases, Ludwik Rydygier Collegium Medicum in Bydgoszcz, Nicolaus Copernicus University in Torun, Dr Jan Biziel University Hospital No. 2 in Bydgoszcz, Poland.
  • Alska E; Department and Clinic of Allergology, Clinical Immunology and Internal Diseases, Ludwik Rydygier Collegium Medicum in Bydgoszcz, Nicolaus Copernicus University in Torun, Dr Jan Biziel University Hospital No. 2 in Bydgoszcz, Poland.
  • Paulina K; Students' Scientific Club of Clinical Immunology and Internal Diseases At, Department and Clinic of Allergology, Clinical Immunology and Internal Diseases, Ludwik Rydygier Collegium Medicum in Bydgoszcz, Nicolaus Copernicus University in Torun, Dr Jan Biziel University Hospital No. 2 in Bydgoszcz, P
  • Czarnowska M; Students' Scientific Club of Clinical Immunology and Internal Diseases At, Department and Clinic of Allergology, Clinical Immunology and Internal Diseases, Ludwik Rydygier Collegium Medicum in Bydgoszcz, Nicolaus Copernicus University in Torun, Dr Jan Biziel University Hospital No. 2 in Bydgoszcz, P
  • Bartuzi Z; Department and Clinic of Allergology, Clinical Immunology and Internal Diseases, Ludwik Rydygier Collegium Medicum in Bydgoszcz, Nicolaus Copernicus University in Torun, Dr Jan Biziel University Hospital No. 2 in Bydgoszcz, Poland.
Public Health Pract (Oxf) ; 5: 100354, 2023 Jun.
Article in English | MEDLINE | ID: covidwho-2244691
ABSTRACT

Objectives:

The aim of this study was to determine the degree of safety and possible risk of acute allergic reactions following mRNA COVID-19 vaccination among a group of patients predisposed to allergic diseases. Study

design:

The study survey took place between May 2021 and February 2022. Each participant completed an initial pre-vaccination questionnaire during patient eligibility assessment for vaccination, and two subsequent questionnaires were completed approximately 21 days after the first and second doses of vaccination.

Methods:

The study included 52 patients aged >18 years. Participants were a select group of patients who, due to a history of severe allergic disease, were not eligible for vaccination at the COVID-19 Vaccination Points available in Poland.

Results:

None of the patients developed serious allergic complications in the form of anaphylaxis. There were no statistically significant differences between the first vaccination and the second vaccination in terms of symptoms, the time of onset and duration. The age of the participants did not correlate statistically with the occurrence of symptoms following the first or second vaccination.

Conclusions:

Based on the study results, it can be concluded that mRNA COVID-19 vaccines show a favourable safety profile for patients with a history of allergic disease and constitute the optimal strategy for fighting the SARS-CoV-2 pandemic. The study results support the recommendation of COVID-19 vaccinations for people predisposed to allergic diseases due to the clear benefits of vaccination over the possible risk of adverse events.

Full text: Available Collection: International databases Database: MEDLINE Type of study: Observational study / Prognostic study Topics: Vaccines Language: English Journal: Public Health Pract (Oxf) Year: 2023 Document Type: Article Affiliation country: J.puhip.2022.100354

Similar

MEDLINE

...
LILACS

LIS


Full text: Available Collection: International databases Database: MEDLINE Type of study: Observational study / Prognostic study Topics: Vaccines Language: English Journal: Public Health Pract (Oxf) Year: 2023 Document Type: Article Affiliation country: J.puhip.2022.100354